{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:03:54Z","timestamp":1790276634353,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neuropharm.2016.02.030","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T07:30:17Z","timestamp":1456558217000},"page":"286-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"PB","title":["Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions"],"prefix":"10.1016","volume":"112","author":[{"given":"Barbara","family":"Strasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Gostner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.02.030_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","article-title":"Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway","volume":"41","author":"Ball","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1381\/096089206776945066","article-title":"Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients","volume":"16","author":"Brandacher","year":"2006","journal-title":"Obes. Surg."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2007.09.005","article-title":"IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection","volume":"108","author":"Bellmann-Weiler","year":"2008","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib6","first-page":"271","article-title":"5-Hydroxytryptophan: a clinically-effective serotonin precursor","volume":"3","author":"Birdsall","year":"1998","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jpsychires.2006.02.001","article-title":"Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin","volume":"41","author":"Blasko","year":"2007","journal-title":"J.\u00a0Psych. Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/ajplegacy.1968.214.3.525","article-title":"Potentiation of endotoxin shock by oral L-tryptophan","volume":"214","author":"Boruchow","year":"1968","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3- dioxygenase expression in colorectal cancer: impact on tumor-infiltrating T-cells","volume":"12","author":"Brandacher","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","article-title":"Chronic low grade immune activation in the elderly is associated with increased tryptophan catabolism and altered phenylalanine turnover: role in neuropsychiatric symptomatology","volume":"70","author":"Capuron","year":"2011","journal-title":"Biol. Psych."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(01)00418-0","article-title":"Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages","volume":"120","author":"Chiarugi","year":"2001","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib14","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1073\/pnas.1517820112","article-title":"Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development","volume":"112","author":"Cole","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2893.2005.00706.x","article-title":"Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients","volume":"13","author":"Cozzi","year":"2006","journal-title":"J.\u00a0Viral. Hepat."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib16","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.4049\/jimmunol.179.8.5246","article-title":"Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege","volume":"179","author":"Cuffy","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2354.2009.01122.x","article-title":"Increased tryptophan degradation in patients with bronchus carcinoma","volume":"19","author":"Engin","year":"2010","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4615-0135-0_21","article-title":"T\u00a0cell apoptosis by kynurenines","volume":"527","author":"Fallarino","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib20","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/oby.21199","article-title":"The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation","volume":"23","author":"Favennec","year":"2015","journal-title":"Obes. Silver Spring"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF02256538","article-title":"Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease","volume":"9","author":"Forrest","year":"2002","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib22","first-page":"2629","article-title":"Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer","volume":"31","author":"Fotopoulou","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clinbiochem.2004.02.007","article-title":"Ageing Increasing production of homocysteine and neopterin and degradation of tryptophan with older age","volume":"37","author":"Frick","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-2478(89)90120-X","article-title":"Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation","volume":"23","author":"Fuchs","year":"1989","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02715666","article-title":"Neopterin as an index of immune response in patients with tuberculosis","volume":"162","author":"Fuchs","year":"1984","journal-title":"Lung"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib26","first-page":"873","article-title":"Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic\/psychiatric symptoms","volume":"3","author":"Fuchs","year":"1990","journal-title":"J.\u00a0Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/jir.1990.10.599","article-title":"Immune activation and decreased tryptophan in patients with HIV-1 infection","volume":"10","author":"Fuchs","year":"1990","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib28","first-page":"271","article-title":"Kynurenine in cerebrospinal fluid of patients with Lyme neuroborreliosis","volume":"1","author":"Fuchs","year":"1991","journal-title":"Immunol. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1515\/CCLM.2001.113","article-title":"Is hyperhomocysteinemia due to oxidative depletion of folate rather than insufficient dietary intake","volume":"39","author":"Fuchs","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-2478(91)90005-U","article-title":"Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection","volume":"28","author":"Fuchs","year":"1991","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2362.2011.02491.x","article-title":"Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study","volume":"41","author":"Furuzawa-Carballeda","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.bbi.2011.06.001","article-title":"Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C","volume":"25","author":"Galv\u00e3o-de Almeida","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A\u00a0genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib34","first-page":"699","article-title":"Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis, and adult T-cell leukemia\/lymphoma","volume":"5","author":"Giusti","year":"1996","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1179\/1351000213Y.0000000044","article-title":"Redox regulation of the immune response","volume":"18","author":"Gostner","year":"2013","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/13816128113199990047","article-title":"Immunoregulatory impact of food antioxidants","volume":"20","author":"Gostner","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fpsyt.2015.00097","article-title":"Disturbed amino acid metabolism in HIV: association with neuropsychiatric symptoms","volume":"6","author":"Gostner","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients","volume":"40","author":"Heyes","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib41","first-page":"288","article-title":"Indoleamine 2,3-dioxygenase. Note I. Catalytic and molecular properties","volume":"29","author":"Hirata","year":"1975","journal-title":"Acta. Vitaminol. Enzymol."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.02.030_bib42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ismej.2015.127","article-title":"Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice","volume":"10","author":"Hoffmann","year":"2016","journal-title":"ISME J."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.bjc.6600336","article-title":"Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer","volume":"86","author":"Huang","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psyneuen.2015.06.001","article-title":"Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer","volume":"60","author":"Huefner","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib45","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","article-title":"Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients","volume":"44","author":"Huengsberg","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2006.02.016","article-title":"Immunopathogenesis of cerebral malaria","volume":"36","author":"Hunt","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","article-title":"\u201cSpicing up\u201d of the immune system by curcumin","volume":"27","author":"Jagetia","year":"2007","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib48","first-page":"853","article-title":"The tryptophan loading test as means of detection of pyridoxine deficiency in the child","volume":"14","author":"Jeune","year":"1959","journal-title":"Pediatrie"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s00394-015-1077-9","article-title":"Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease","author":"Karlsson","year":"2015","journal-title":"Eur. J. Nutr"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","article-title":"The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression","volume":"64","author":"Kim","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0065-2571(66)90023-9","article-title":"The regulation of tryptophan pyrrolase activity by tryptophan","volume":"4","author":"Knox","year":"1966","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2010.01.003","article-title":"Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods","volume":"293","author":"Koenigsberg","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2004.12.013","article-title":"Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues","volume":"86","author":"Kohl","year":"2005","journal-title":"J.\u00a0Affect. Dis."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.02.030_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036956","article-title":"Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown","volume":"7","author":"Kurz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jnr.490230410","article-title":"Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection","volume":"23","author":"Larsson","year":"1989","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib56","first-page":"159","article-title":"Serotonin and human immunodeficiency viruses","volume":"31","author":"Launay","year":"1989","journal-title":"Nouv. Rev. Fr. Hematol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated immune system in patients with Huntington's disease","volume":"36","author":"Leblhuber","year":"1998","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib58","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00702-015-1381-9","article-title":"Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut","volume":"122","author":"Leblhuber","year":"2015","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1159\/000375161","article-title":"Antiviral and immunoregulatory effects of indoleamine-2,3-dioxygenase in hepatitis C virus infection","volume":"7","author":"Lepiller","year":"2015","journal-title":"J.\u00a0Innate. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib60","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.3390\/ijms160715150","article-title":"Behavioral deficits are accompanied by immunological and neurochemical changes in a mouse model for neuropsychiatric lupus (NP-SLE)","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib61","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","article-title":"Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib62","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.fct.2010.04.042","article-title":"Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in\u00a0vitro","volume":"48","author":"Maier","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib63","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/0929867311320180004","article-title":"Antioxidant food supplements and obesity-related inflammation","volume":"20","author":"Mangge","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib64","first-page":"293","article-title":"The \u201ckynurenine shunt\u201d and depression","volume":"11","author":"Mangoni","year":"1974","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib65","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1172\/JCI81859","article-title":"IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII","volume":"125","author":"Matino","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.18.1.367","article-title":"Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression","volume":"18","author":"Mellor","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib67","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib69","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s430-001-8023-3","article-title":"Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes","volume":"189","author":"Murr","year":"2001","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/eci.12402","article-title":"Low serum tryptophan predicts higher mortality in cardiovascular disease","volume":"45","author":"Murr","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1473-3099(03)00773-4","article-title":"Tryptophan depletion and HIV infection: a metabolic link to pathogenesis","volume":"3","author":"Murray","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib73","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1460-9568.2008.06201.x","article-title":"Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat","volume":"27","author":"Nakatani","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib134","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/AOG.0b013e318255004e","article-title":"Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia","volume":"119","author":"Nilsen","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/74680","article-title":"Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway","volume":"6","author":"Otterbein","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib75","article-title":"Disturbances of tryptophan metabolism and risk of depression in HCV patients treated with IFN-alpha","volume":"2","author":"Oxenkrug","year":"2014","journal-title":"J.\u00a0Infect. Dis. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib76","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"21","author":"Pallotta","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib78","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/ATVBAHA.110.219329","article-title":"Systemic markers of interferon-\u03b3-mediated immune activation and long-term prognosis in patients with stable coronary artery disease","volume":"31","author":"Pedersen","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/ATVBAHA.114.304674","article-title":"Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris","volume":"35","author":"Pedersen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib80","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/eurheartj\/eht264","article-title":"Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography","volume":"34","author":"Pedersen","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib81","first-page":"209","article-title":"Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma","volume":"23","author":"Pellegrin","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/IJTR.S3983","article-title":"Accelerated tryptophan degradation predicts poor survival in trauma and sepsis patients","volume":"3","author":"Ploder","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1042\/BST0370408","article-title":"Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase","volume":"37","author":"Rafice","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib84","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2011.05.031","article-title":"Treating the periphery to ameliorate neurodegenerative diseases","volume":"145","author":"Reinhart","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1515\/pteridines.2001.12.3.130","article-title":"Association between increased serum neopterin and homocysteine concentrations as well as pyridoxal phosphate deficiency in patients with coronary heart disease","volume":"12","author":"Rudzite","year":"2001","journal-title":"Pteridines"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib87","first-page":"611","article-title":"Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria","volume":"152","author":"Sanni","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib88","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fimmu.2014.00384","article-title":"New insights into IDO biology in bacterial and viral infections","volume":"5","author":"Schmidt","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0029-7844(96)00084-1","article-title":"Decreased plasma tryptophan in pregnancy","volume":"88","author":"Schr\u00f6cksnadel","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib90","first-page":"1935","article-title":"Increased degradation of tryptophan in blood of patients with rheumatoid arthritis","volume":"30","author":"Schroecksnadel","year":"2003","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib91","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.canlet.2004.10.033","article-title":"Tryptophan degradation in patients with gynecological cancer correlates with immune activation","volume":"223","author":"Schroecksnadel","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib92","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","article-title":"Diminished quality of life in patients with cancer correlates with tryptophan degradation","volume":"133","author":"Schroecksnadel","year":"2007","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib93","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schroecksnadel","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib94","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2007.12.011","article-title":"Quality of life and immune activation in patients with HIV-infection","volume":"22","author":"Schroecksnadel","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib95","first-page":"1","article-title":"Immune activation and neuropsychiatric symptoms in HIV-1 infection","volume":"3","author":"Schroecksnadel","year":"2012","journal-title":"Neurobehav. HIV Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib96","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.410240417","article-title":"Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia","volume":"24","author":"Schwarcz","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib97","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1542\/peds.47.1.47","article-title":"Excretion of kynurenic acid and xanthurenic acid during infection","volume":"47","author":"Shaw","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib99","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00004647-199806000-00002","article-title":"Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans","volume":"18","author":"Sinz","year":"1998","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib100","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/mp.2011.67","article-title":"Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-\u03b1-induced depression in patients with chronic hepatitis C","volume":"17","author":"Smith","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib101","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1601-5215.2009.00413.x","article-title":"Nutrition, mood and behaviour: a review","volume":"21","author":"Soh","year":"2009","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.imbio.2010.07.010","article-title":"Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers","volume":"216","author":"Sperner-Unterweger","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib103","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YCO.0000000000000153","article-title":"Schizophrenia and psychoneuroimmunology: an integrative view","volume":"28","author":"Sperner-Unterweger","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib104","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.npbr.2015.07.002","article-title":"Role of physical activity and diet on mood, behavior, and cognition","author":"Strasser","year":"2015","journal-title":"Neurol. Psychiatry Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00394-014-0690-3","article-title":"Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults","volume":"54","author":"Strasser","year":"2015","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib107","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/CVI.05402-11","article-title":"Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis","volume":"19","author":"Suzuki","year":"2012","journal-title":"Clin. Vaccine. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib108","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/187152710793237430","article-title":"Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease","volume":"9","author":"Thevandavakkam","year":"2010","journal-title":"C.N.S. Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib109","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1016\/S0021-9258(17)36645-0","article-title":"Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes","volume":"269","author":"Thomas","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3945\/ajcn.114.083196","article-title":"Evidence for increased catabolism of vitamin B-6 during systemic inflammation","volume":"100","author":"Ulvik","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib111","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib112","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/brain\/awh130","article-title":"CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy","volume":"127","author":"Valle","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib113","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jad.2015.09.064","article-title":"Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression","volume":"189","author":"Veen","year":"2015","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib114","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.2092","article-title":"Kynurenine is an endothelium-derived relaxing factor produced during inflammation","volume":"16","author":"Wang","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000096906","article-title":"Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients","volume":"214","author":"Weinlich","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S13958","article-title":"Kynurenic acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies","volume":"7","author":"Wennstr\u00f6m","year":"2014","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0024-3205(87)90149-4","article-title":"Human macrophages degrade tryptophan upon induction by interferon-gamma","volume":"41","author":"Werner","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib118","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1515\/bchm3.1988.369.1.337","article-title":"Tryptophan degradation in patients infected by human immunodeficiency virus","volume":"369","author":"Werner","year":"1988","journal-title":"Biol. Chem. Hoppe. Seyler"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib119","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0167-4889(89)90087-6","article-title":"Characteristics of interferon induced tryptophan metabolism in human cells in\u00a0vitro","volume":"1012","author":"Werner-Felmayer","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1515\/pteridines.1994.5.4.142","article-title":"Neopterin, \u00df2-microglobulin, tryptophan and kynurenine in sporadic amyotrophic lateral sclerosis","volume":"5","author":"Westarp","year":"1992","journal-title":"Pteridines"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib121","first-page":"327","article-title":"Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses","volume":"2","author":"Westarp","year":"1993","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib122","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0171-2985(00)80079-0","article-title":"Enhanced tryptophan degradation in systemic lupus erythematosus","volume":"201","author":"Widner","year":"2000","journal-title":"Immunobiology"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s007020050029","article-title":"Tryptophan degradation and immune activation in Alzheimer's disease","volume":"107","author":"Widner","year":"2000","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib124","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib125","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production tryptophan degradation and mental depression: what is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib126","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1189\/jlb.72.6.1148","article-title":"Monocyte-derived dendritic cells release neopterin","volume":"72","author":"Wirleitner","year":"2002","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib127","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2362.2003.01186.x","article-title":"Immune activation and degradation of tryptophan in coronary heart disease","volume":"33","author":"Wirleitner","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2004.05.004","article-title":"Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease","volume":"113","author":"Wolf","year":"2004","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.02.030_bib129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.28282","article-title":"Indoleamine 2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B","volume":"63","author":"Yoshio","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/clim.2002.5231","article-title":"Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection","volume":"104","author":"Zangerle","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib131","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2Areceptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.030_bib132","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/ph8020337","article-title":"Tryptophan breakdown in patients with HCV infection is influenced by IL28B polymorphism","volume":"8","author":"Zoller","year":"2015","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.neuropharm.2016.02.030_bib133","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:15:10Z","timestamp":1718370910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081630065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":132,"alternative-id":["S002839081630065X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.030","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}